Cancer‐testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: Its association with prognosis

INTRODUCTION: Cancer testis (CT) antigens are attractive targets for cancer immunotherapy because of their expression restriction and immunogenicity. The acrosin binding protein (ACRBP) is a member of CT antigens. This study aimed to evaluate ACRBP expression and immunogenicity in ovarian cancer (OC...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Lina, Nong, Weixia, Luo, Bin, Ge, Yingying, Zeng, Xia, Li, Feng, Fan, Rong, Zhang, Qingmei, Xie, Xiaoxun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589352/
https://www.ncbi.nlm.nih.gov/pubmed/34528758
http://dx.doi.org/10.1002/iid3.534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589352/
https://www.ncbi.nlm.nih.gov/pubmed/34528758
http://dx.doi.org/10.1002/iid3.534

Ejemplares similares